Literature DB >> 7979189

Dexamethasone induced partial resistance to methotrexate in C6-glioma cells.

J E Wolff1, H Jürgens.   

Abstract

Chemotherapy results in glioma are poor. In addition to chemotherapy most patients are treated with dexamethasone (Dex) to reduce brain edema. Therefore we examined the influence of Dex on the sensitivity of C6 glioma cells to methotrexate (MTX) using MTT-tests. The LD50 of MTX was 3*10(-8)M, 10(-7)M, 4*10(-6)M and 4*10(-4)M after 72, 24, 6 and 1 hour treatment, respectively. After incubations with combinations of Dex and MTX, twice as many cells survived high MTX concentrations. This protection could be overcome by addition of 10 to 100 fold more MTX. It was not species-specific since the effect was also found in human TE671 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979189

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Dexamethasone differentially regulates functional membrane properties in glioma cell lines and primary astrocytes in vitro.

Authors:  Daniel Hinkerohe; Dörte Wolfkühler; Aiden Haghikia; Carola Meier; Pedro M Faustmann; Uwe Schlegel
Journal:  J Neurooncol       Date:  2010-11-24       Impact factor: 4.130

2.  Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone.

Authors:  B Kaup; I Schindler; H Knüpfer; A Schlenzka; R Preiss; M M Knüpfer
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

3.  High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D pilot study.

Authors:  Johannes E Wolff; Rolf-Dieter Kortmann; Birte Wolff; Torsten Pietsch; Ove Peters; Hans-Joerg Schmid; Stefan Rutkowski; Monika Warmuth-Metz; Christoph Kramm
Journal:  J Neurooncol       Date:  2010-08-08       Impact factor: 4.130

4.  Histone acetylation resulting in resistance to methotrexate in choroid plexus cells.

Authors:  Preethi Prasad; Hernan Vasquez; Chandra M Das; Vidya Gopalakrishnan; Johannes E A Wolff
Journal:  J Neurooncol       Date:  2008-10-14       Impact factor: 4.130

Review 5.  Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms.

Authors:  Roger Murayi; Prashant Chittiboina
Journal:  Childs Nerv Syst       Date:  2016-09-09       Impact factor: 1.475

6.  Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities.

Authors:  Arabinda Das; Naren L Banik; Sunil J Patel; Swapan K Ray
Journal:  Mol Cancer       Date:  2004-12-08       Impact factor: 27.401

Review 7.  Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments.

Authors:  Nora Sundahl; Dorien Clarisse; Marc Bracke; Fritz Offner; Wim Vanden Berghe; Ilse M Beck
Journal:  Oncoscience       Date:  2016-07-27

8.  Dexamethasone inhibits proliferation and stimulates ecto-5'-nucleotidase/CD73 activity in C6 rat glioma cell line.

Authors:  Luci Bavaresco; Andressa Bernardi; Elizandra Braganhol; Márcia R Wink; Ana Maria Oliveira Battastini
Journal:  J Neurooncol       Date:  2007-04-24       Impact factor: 4.506

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.